Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 116


A novel homozygous deletion in EXPH5 causes a skin fragility phenotype.

Malchin N, Sarig O, Grafi-Cohen M, Geller S, Goldberg I, Shani A, Gat A, Sprecher E, Mashiah J.

Clin Exp Dermatol. 2016 Dec;41(8):915-918. doi: 10.1111/ced.12908. Epub 2016 Oct 11.


Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients.

Brenner B, Geva R, Rothney M, Beny A, Dror Y, Steiner M, Hubert A, Idelevich E, Gluzman A, Purim O, Shacham-Shmueli E, Shulman K, Mishaeli M, Man S, Soussan-Gutman L, Tezcan H, Chao C, Shani A, Liebermann N.

Value Health. 2016 Jan;19(1):82-7. doi: 10.1016/j.jval.2015.08.013. Epub 2015 Oct 30.


Passive transfer of affinity-purified anti-heart autoantibodies (AHA) from sera of patients with myocarditis induces experimental myocarditis in mice.

Caforio AL, Angelini A, Blank M, Shani A, Kivity S, Goddard G, Doria A, Schiavo A, Testolina M, Bottaro S, Marcolongo R, Thiene G, Iliceto S, Shoenfeld Y.

Int J Cardiol. 2015 Jan 20;179:166-77. doi: 10.1016/j.ijcard.2014.10.165. Epub 2014 Oct 29.


Oncologists' and family physicians' views on value for money of cancer and congestive heart failure care.

Greenberg D, Hammerman A, Vinker S, Shani A, Yermiahu Y, Neumann PJ.

Isr J Health Policy Res. 2013 Nov 18;2:44. doi: 10.1186/2045-4015-2-44. eCollection 2013.


Which is more valuable, longer survival or better quality of life? Israeli oncologists' and family physicians' attitudes toward the relative value of new cancer and congestive heart failure interventions.

Greenberg D, Hammerman A, Vinker S, Shani A, Yermiahu Y, Neumann PJ.

Value Health. 2013 Jul-Aug;16(5):842-7. doi: 10.1016/j.jval.2013.04.010. Epub 2013 Jul 11.


Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.

Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group..

Lancet. 2013 Mar 9;381(9869):805-16. Erratum in: Lancet. 2013 Mar 9;381(9869):804.


Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D; CORRECT Study Group..

Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012 Nov 22.


Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.

Mieog JS, Morden JP, Bliss JM, Coombes RC, van de Velde CJ; IES Steering Committee..

Lancet Oncol. 2012 Apr;13(4):420-32. doi: 10.1016/S1470-2045(11)70328-X. Epub 2012 Jan 20.


Percutaneous augmented instrumentation of unstable thoracolumbar burst fractures.

Rahamimov N, Mulla H, Shani A, Freiman S.

Eur Spine J. 2012 May;21(5):850-4. doi: 10.1007/s00586-011-2106-x. Epub 2011 Dec 8.


Cetuximab in metastatic colorectal cancer.

Wolf I, Golan T, Shani A, Aderka D.

Lancet Oncol. 2010 Apr;11(4):313-4; author reply 314. doi: 10.1016/S1470-2045(10)70019-X. No abstract available.


Phase II study of UFT with leucovorin plus hepatic arterial infusion with irinotecan, 5-fluorouracil and leucovorin for non-resectable liver metastases of colorectal cancer.

Idelevich E, Greif F, Mavor E, Miller R, Kashtan H, Susmalian S, Ariche A, Brenner B, Baruch NB, Dinerman M, Shani A.

Chemotherapy. 2009;55(2):76-82. doi: 10.1159/000183732. Epub 2008 Dec 12.


Slow release of pheromones to the atmosphere from gelatin-alginate beads.

Yosha I, Shani A, Magdassi S.

J Agric Food Chem. 2008 Sep 10;56(17):8045-9. doi: 10.1021/jf800772g. Epub 2008 Aug 9.


Enhanced percutaneous permeability of diclofenac using a new U-type dilutable microemulsion.

Shevachman M, Garti N, Shani A, Sintov AC.

Drug Dev Ind Pharm. 2008 Apr;34(4):403-12. doi: 10.1080/03639040701662479 .


An association of Hutchinson-Gilford progeria and malignancy.

Shalev SA, De Sandre-Giovannoli A, Shani AA, Levy N.

Am J Med Genet A. 2007 Aug 15;143A(16):1821-6.


Phase II study of cisplatin, epirubicin, UFT, and leucovorin (PELUF) as first-line chemotherapy in metastatic gastric cancer.

Idelevich E, Karminsky N, Dinerman M, Katsenelson RL, Zvi NB, Baruch NB, Biran H, Man S, Shani A.

Acta Oncol. 2007;46(3):324-9.


Reduced repair of the oxidative 8-oxoguanine DNA damage and risk of head and neck cancer.

Paz-Elizur T, Ben-Yosef R, Elinger D, Vexler A, Krupsky M, Berrebi A, Shani A, Schechtman E, Freedman L, Livneh Z.

Cancer Res. 2006 Dec 15;66(24):11683-9.


Risk factors for maternal intrapartum fever and short-term neonatal outcome.

Maayan-Metzger A, Mazkereth R, Shani A, Kuint J.

Fetal Pediatr Pathol. 2006 May-Jun;25(3):169-77.


Preoperative chemoradiation in rectal cancer: Retrospective comparison between capecitabine and continuous infusion of 5-fluorouracil.

Yerushalmi R, Idelevich E, Dror Y, Stemmer SM, Figer A, Sulkes A, Brenner B, Loven D, Dreznik Z, Nudelman I, Shani A, Fenig E.

J Surg Oncol. 2006 Jun 1;93(7):529-33.


Supplemental Content

Loading ...
Support Center